Table 2.
Summary of the biochemical and antiviral features of the examined variants
n.d., not determined; MR, minireplicon assay; infection, virus infection experiments analyzed by FACS; VLP, VLP infection assay.
* Experiments were performed with the monomeric M527D mutant.
# Data at 20 μm protein concentraion.
§ Data from Dick et al. (9).
